Holen Sie sich die Stockscreener-App
15.34
2.47%
-0.46
Schlusskurs vom Vortag:
$15.80
Offen:
$16
24-Stunden-Volumen:
149.06K
Relative Volume:
0.07
Marktkapitalisierung:
$1.63B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-766.97M
KGV:
-2.0026
EPS:
-7.66
Netto-Cashflow:
$-646.43M
1W Leistung:
-2.96%
1M Leistung:
+10.62%
6M Leistung:
-12.54%
1J Leistung:
-71.32%
1-Tages-Spanne:
$15.37
$16.00
1-Wochen-Bereich:
$14.98
$17.61
52-Wochen-Spanne:
$12.79
$54.98
Biohaven Ltd Stock (BHVN) Company Profile
Firmenname
Biohaven Ltd
Sektor
Branche
Telefon
203-404-0410
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie BHVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
15.37 | 1.67B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.40 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Citigroup | Buy |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-19 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-16 | Eingeleitet | Jefferies | Buy |
| 2024-09-04 | Eingeleitet | Bernstein | Outperform |
| 2024-07-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2023-12-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-01-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-04 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-02 | Eingeleitet | BTIG Research | Buy |
| 2022-10-26 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-05-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2021-08-03 | Bestätigt | Canaccord Genuity | Buy |
| 2021-03-11 | Eingeleitet | UBS | Buy |
| 2020-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-17 | Eingeleitet | Cowen | Outperform |
| 2020-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2019-11-22 | Eingeleitet | Wedbush | Outperform |
| 2019-06-25 | Bestätigt | Canaccord Genuity | Buy |
| 2019-05-06 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Bestätigt | Needham | Buy |
| 2018-07-03 | Bestätigt | Needham | Buy |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-04-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Bestätigt | Canaccord Genuity | Buy |
| 2017-12-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-03 | Bestätigt | Needham | Buy |
Alle ansehen
Biohaven Ltd Aktie (BHVN) Neueste Nachrichten
Will Biohaven Ltd. stock remain a Wall Street favoriteJuly 2025 Retail & Weekly High Return Opportunities - newser.com
Biohaven Ltd. stock chart pattern explainedCPI Data & Free Community Supported Trade Ideas - newser.com
Will Biohaven Ltd. stock pay special dividends2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Biohaven Ltd. see short term momentumQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
How to recover losses in Biohaven Ltd. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com
Biohaven (NYSE:BHVN) Trading 7% HigherStill a Buy? - MarketBeat
Weiss Ratings Reaffirms "Sell (E+)" Rating for Biohaven (NYSE:BHVN) - MarketBeat
Pfizer settles Biohaven kickback case with DOJ for $60M - MSN
Leading vs lagging indicators on Biohaven Ltd. performanceWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Will Biohaven Ltd. Common Shares stock outperform energy sector in 2025Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Should Biohaven's (BHVN) Accelerating Cash Burn and Shorter Runway Require Action From Investors? - simplywall.st
New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal
Biohaven (NYSE:BHVN) Trading Down 4.6%Here's Why - MarketBeat
A Look at Biohaven (BHVN) Valuation as Cash Runway Narrows and Funding Concerns Grow - simplywall.st
Biohaven Ltd.’s volatility index tracking explainedQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com
Biohaven Ltd. stock trend forecastIndex Update & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-06 07:41:08 - newser.com
Published on: 2025-10-05 05:51:51 - newser.com
Is Biohaven Ltd. Common Shares stock a contrarian opportunityQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Biohaven Ltd. recovery potential after sell off2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Sentiment analysis tools applied to Biohaven Ltd.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Regression analysis insights on Biohaven Ltd. performanceStop Loss & Short-Term High Return Strategies - newser.com
What indicators show strength in Biohaven Ltd.Long Setup & Real-Time Chart Breakout Alerts - newser.com
Is Biohaven Ltd. stock a good choice for value investorsRisk Management & Free Community Consensus Stock Picks - newser.com
Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - MSN
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Published on: 2025-09-29 05:11:50 - newser.com
Finanzdaten der Biohaven Ltd-Aktie (BHVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biohaven Ltd-Aktie (BHVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Car Bruce | Chief Scientific Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,750 |
0 |
7,133 |
| Gentile Kimberly | SVP, Clinical Operations |
Jan 05 '25 |
Option Exercise |
0.00 |
3,750 |
0 |
99,719 |
| Clark George C. | VP, Chief Accounting Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
66,168 |
| Buten Matthew | Chief Financial Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,250 |
0 |
196,013 |
| Coric Vlad | Chief Executive Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
14,250 |
0 |
1,803,409 |
| CHILDS JOHN W | Director |
Dec 30 '24 |
Buy |
35.94 |
29,000 |
1,042,393 |
2,368,741 |
0.21%
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):